MELISSA ENGLISH: Open Payments
NPI 1881693588 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 53 payments from 25 companies in 2025. Trend: 2023 $631 · 2024 $1,112 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $178 |
| Novartis Pharmaceuticals Corporation | 6 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $51 |
| Pharmacosmos Therapeutics Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Stemline Therapeutics Inc. | 2 | $37 |
| ARRAY BIOPHARMA INC | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: Nubeqa, FRUZAQLA, SCEMBLIX, EPKINLY, TALVEY, Fabhalta, NINLARO, MONOFERRIC.
Industry payments across AL — which companies pay providers there.
